You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Natural killer cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Jakarta Pusat (Autologous Natural Killer Cell Therapy, Clinimacs Plus)

Recruiting
  • Hepatocellular Carcinoma
  • Autologous Natural Killer Cell Therapy
  • Clinimacs Plus
  • Jakarta Pusat, Jakarta, Indonesia
    Cipto Mangunkusumo General Hospital
Sep 24, 2023

Autologous Natural Killer Cell Activity in Primary Cancer Cell

Recruiting
  • Sarcoma
    • Santa Monica, California
      Sarcoma Oncology Research Center
    May 19, 2023

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

    Not yet recruiting
    • Acute Myeloid Leukemia
    • NK cells
    • Talazoparib 1 MG [Talzenna]
    • (no location specified)
    Jan 9, 2023

    Immunity, Innate, Colorectal Cancer Trial in Montreal (IVDD for NK cell activity in whole blood)

    Terminated
    • Immunity, Innate
    • Colorectal Cancer
    • IVDD for NK cell activity in whole blood
    • Montreal, Quebec, Canada
    • +2 more
    Jan 30, 2023

    Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

    Withdrawn
    • Leukemia
    • Donor Enriched Activated Natural Killer Cell Infusion
    • (no location specified)
    Dec 20, 2022

    Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

    Recruiting
    • Neuroblastoma Recurrent
    • Natural killer cell
    • +4 more
    • Hong Kong, Hong Kong
      Hong Kong Children's Hospital
    Feb 22, 2023

    Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

    Recruiting
    • Glioblastoma
    • GBM
    • Suzhou, Jiangsu, China
      Dushu Lake Hospital Affiliated to Soochow University
    Nov 23, 2023

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 28, 2022

    Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

    Active, not recruiting
    • Plasma Cell Leukemia
    • Plasma Cell Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

    Recruiting
    • Recurrent Adult T-Cell Leukemia/Lymphoma
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 18, 2022

    AML Trial in Hangzhou (NKG2D CAR-NK)

    Recruiting
    • AML
    • NKG2D CAR-NK
    • Hangzhou, Zhejiang, China
    • +1 more
    Feb 17, 2023

    Solid Tumor Trial in Yantai (NK combined with Chemotherapy, Chemotherapy)

    Recruiting
    • Solid Tumor
    • Yantai, Shandong, China
      Yantai Yuhuangding Hospital
    Feb 7, 2022

    Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor

    Not yet recruiting
    • Pediatric Brain Tumor
    • +2 more
    • Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
    • Implantation
    • San Francisco, California
      University of California, San Francisco
    May 24, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Hangzhou (BCMA CAR-NK, Cyclophosphamide, Fludarabine

    Recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • BCMA CAR-NK
    • +2 more
    • Hangzhou, Zhejiang, China
    • +1 more
    Feb 17, 2023

    Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

    Completed
    Has Results
    • Leukemia
    • Lymphoma
    • Total Lymphoid Irradiation
    • +10 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 28, 2022

    Pain, Anesthesia, Cancer Trial in Los Angeles (Bupivacaine + Fentanyl, Bupivacaine)

    Enrolling by invitation
    • Pain
    • +2 more
    • Los Angeles, California
      Cedars Sinai Medical Center
    Feb 9, 2022

    Acute Myeloid Leukemia Trial in Los Angeles (Haploidentical IL-21-Expanded Natural Killer Cells)

    Enrolling by invitation
    • Acute Myeloid Leukemia
    • Haploidentical IL-21-Expanded Natural Killer Cells
    • Los Angeles, California
      Children's Hospital Los Angeles
    Nov 1, 2021

    Allogenic Stem Cell Transplantation Trial (SAR445419)

    Not yet recruiting
    • Allogenic Stem Cell Transplantation
    • (no location specified)
    Feb 13, 2023

    Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

    Completed
    • Chronic Myeloid Leukemia (CML)
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 31, 2022

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult Trial in Nijmegen (UCB-NK cells, IL-2)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, Relapsed, Adult
    • Nijmegen, Netherlands
      Radboud University Medical Center
    Nov 10, 2021

    Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

    Completed
    • Multiple Myeloma
    • +7 more
    • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 2, 2022

    Healthy Volunteers Trial in Jackson (Immulina TM, Placebo)

    Recruiting
    • Healthy Volunteers
    • Immulina TM
    • Placebo
    • Jackson, Mississippi
      University of Mississippi Medical Center
    Aug 23, 2022

    Extranodal Natural Killer T Cell Lymphoma Trial in China (Tislelizumab combined with Liposomal mitoxantrone HCl, Maintenance of

    Recruiting
    • Extranodal Natural Killer T Cell Lymphoma
    • Tislelizumab combined with Liposomal mitoxantrone hydrochloride
    • Maintenance of tislelizumab
    • Beijing, China
    • +5 more
    Jul 15, 2022

    NSCLC, Gastric Cancer, Hepatocellular Carcinoma Trial in Beijing, Shanghai (natural killer T cell)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • natural killer T cell
    • Beijing, China
    • +1 more
    Apr 26, 2022